426 related articles for article (PubMed ID: 7962539)
1. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.
Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ
J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539
[TBL] [Abstract][Full Text] [Related]
2. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
Sano T; Morishita Y; Matsuda Y; Yamada K
J Pharmacol Exp Ther; 1992 Feb; 260(2):825-31. PubMed ID: 1346647
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms of action of atrial natriuretic factor.
Gerzer R; Heim JM; Schütte B; Weil J
Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic factor stimulates exocrine pancreatic secretion in the rat through NPR-C receptors.
Sabbatini ME; Villagra A; Davio CA; Vatta MS; Fernandez BE; Bianciotti LG
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G929-37. PubMed ID: 12829435
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of action of atrial natriuretic factor: clinical consequences.
Gerzer R; Weil J; Strom T; Müller T
Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
8. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic factor stimulates renal dopamine uptake mediated by natriuretic peptide-type A receptor.
Fernández BE; Correa AH; Choi MR
Regul Pept; 2005 Jan; 124(1-3):137-44. PubMed ID: 15544851
[TBL] [Abstract][Full Text] [Related]
11. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1990 Nov; 255(2):497-503. PubMed ID: 1978729
[TBL] [Abstract][Full Text] [Related]
12. Is cyclic GMP a clinically useful marker for ANF action?
Heim JM; Gottmann K; Weil J; Haufe MC; Gerzer R
Z Kardiol; 1988; 77 Suppl 2():41-6. PubMed ID: 2841815
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.
Trachte GJ
J Pharmacol Exp Ther; 1993 Mar; 264(3):1227-33. PubMed ID: 8095549
[TBL] [Abstract][Full Text] [Related]
14. Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome.
Watanabe H; Lau DC; Guyn HL; Wong NL
Clin Invest Med; 1997 Aug; 20(4):211-23. PubMed ID: 9258576
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats.
Willenbrock RC; Tremblay J; Garcia R; Hamet P
J Clin Invest; 1989 Feb; 83(2):482-9. PubMed ID: 2536399
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptide-induced relaxation of myometrium from the pregnant guinea pig is not mediated by guanylate cyclase activation.
Carvajal JA; Aguan K; Thompson LP; Buhimschi IA; Weiner CP
J Pharmacol Exp Ther; 2001 Apr; 297(1):181-8. PubMed ID: 11259543
[TBL] [Abstract][Full Text] [Related]
17. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
19. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
[TBL] [Abstract][Full Text] [Related]
20. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
